Tme Pharma N.v. Stock
Price
Target price
€0.16
€0.16
-8.280%
-0.014
-8.280%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Tme Pharma N.v. Stock
Tme Pharma N.v. took a tumble today and lost -€0.014 (-8.280%).
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Tme Pharma N.v. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Tme Pharma N.v. in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
News
TME Pharma Announces Strategic Plan to Externalize and Monetize Second Clinical Stage Asset NOX-E36
TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME)
TME Pharma Announces Oral Presentation of NOX-A12 GLORIA Phase 1/2 Trial in Glioblastoma at ESMO Congress 2024
TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME)